Osteonecrosis in Sickle Cell Disease

被引:19
作者
Naseer, Zan A. [1 ]
Bachabi, Malick [1 ]
Jones, Lynne C. [1 ]
Sterling, Robert S. [1 ]
Khanuja, Harpal S. [1 ]
机构
[1] Johns Hopkins Univ, Dept Orthopaed Surg, Baltimore, MD USA
关键词
avascular necrosis; osteonecrosis; orthopedic manifestations; sickle cell disease; total hip arthroplasty; FEMORAL-HEAD OSTEONECROSIS; TOTAL HIP-ARTHROPLASTY; CORE DECOMPRESSION; AVASCULAR NECROSIS; NONTRAUMATIC OSTEONECROSIS; ADULT OSTEONECROSIS; NATURAL-HISTORY; HUMERAL HEAD; BONE; COMPLICATIONS;
D O I
10.14423/SMJ.0000000000000516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteonecrosis is one of the most devastating musculoskeletal manifestations of sickle cell disease and most commonly affects the femoral head. Although the exact pathophysiology of this condition in patients with sickle cell disease is unknown, it is suggested that red cell sickling and repetitive vaso-occlusion may be associated with tissue hypoxia, inflammation, and subsequent bone necrosis and collapse. If left untreated, osteonecrosis can be extremely debilitating and may lead to severe pain, loss of function, and degenerative joint changes. Although several conservative management approaches exist, total joint arthroplasty remains the most effective treatment intervention. A multidisciplinary approach among the primary care physician, hematologist, and orthopedic surgeon is essential in optimizing patient management.
引用
收藏
页码:525 / 530
页数:6
相关论文
共 55 条
  • [1] Bone and joint disease in sickle call disease
    Aguilar, C
    Vichinsky, E
    Neumayr, L
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (05) : 929 - +
  • [2] Multiple drilling compared with standard core decompression for avascular necrosis of the femoral head in sickle cell disease patients
    Al Omran, Abdullah
    [J]. ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2013, 133 (05) : 609 - 613
  • [3] Total hip replacement in sickle cell disease
    Al-Mousawi, F
    Malki, A
    Al-Aradi, A
    Al-Bagali, M
    Al-Sadadi, A
    Booz, MMY
    [J]. INTERNATIONAL ORTHOPAEDICS, 2002, 26 (03) : 157 - 161
  • [4] Managing femoral head osteonecrosis in patients with sickle cell disease
    Al-Mousawi, F. R.
    Malki, A. A.
    [J]. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2007, 5 (05): : 282 - 289
  • [5] American College of Radiology, 2014, ACR APPR CRIT AV NEC
  • [6] Arlet J, 1968, Rev Rhum Mal Osteoartic, V35, P239
  • [7] Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis
    Baldwin, C
    Nolan, VG
    Wyszynski, DF
    Ma, QL
    Sebastiani, P
    Embury, SH
    Bisbee, A
    Farrell, J
    Farrer, L
    Steinberg, MH
    [J]. BLOOD, 2005, 106 (01) : 372 - 375
  • [8] Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head
    Bozic, KJ
    Zurakowski, D
    Thornhill, TS
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (02) : 200 - 209
  • [9] Cabannes R, 1984, BONE CIRCULATION
  • [10] Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery
    Carson, Jeffrey L.
    Terrin, Michael L.
    Noveck, Helaine
    Sanders, David W.
    Chaitman, Bernard R.
    Rhoads, George G.
    Nemo, George
    Dragert, Karen
    Beaupre, Lauren
    Hildebrand, Kevin
    Macaulay, William
    Lewis, Courtland
    Cook, Donald Richard
    Dobbin, Gwendolyn
    Zakriya, Khwaja J.
    Apple, Fred S.
    Horney, Rebecca A.
    Magaziner, Jay
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26) : 2453 - 2462